MET mutations were associated with higher levels of immune cell infiltration according to (i) leukocyte fractions measured by DNA methylation arrays; (ii) lymphocyte fractions estimated from the CIBERSORT algorithm; and (iii) tumor-infiltrating lymphocyte fractions evaluated by RNA-sequencing information (Fig. 3C). The gene discussed is MET; the disease is neoplasm.